{"id":6594,"date":"2023-03-27T01:37:22","date_gmt":"2023-03-27T01:37:22","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=6594"},"modified":"2023-08-29T17:57:23","modified_gmt":"2023-08-29T17:57:23","slug":"impedimed-bis-technology-nccn-includes-oncology-guidelines-lymphoedema-assessment","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=6594","title":{"rendered":"ImpediMed \u7684 BIS \u6280\u672f\u53d7\u5230\u8ba4\u53ef\u4e14\u88ab NCCN \u7eb3\u5165\u80bf\u7624\u5b66\u6307\u5357\uff0c\u7528\u4e8e\u6dcb\u5df4\u6c34\u80bf\u8bc4\u4f30"},"content":{"rendered":"<p>ImpediMed (ASX: IPD) \u5f00\u53d1\u7684\u7528\u4e8e\u8bc4\u4f30\u6dcb\u5df4\u6c34\u80bf\u7684\u7b5b\u67e5\u5e73\u53f0\uff0c\u968f\u7740\u751f\u7269\u963b\u6297\u5149\u8c31 (BIS) \u5ba3\u5e03\u88ab\u7eb3\u5165\u7f8e\u56fd\u56fd\u5bb6\u7efc\u5408\u764c\u75c7\u7f51\u7edc (NCCN) \u53d1\u5e03\u7684\u80bf\u7624\u5b66\u6307\u5357\uff0c\u6709\u671b\u63d0\u9ad8\u5176\u77e5\u540d\u5ea6\u3002<\/p>\n<p>BIS \u5206\u6790\u662f\u4e00\u79cd\u65e0\u521b\u7684\u3001\u4f4e\u6210\u672c\u7684\u7a0b\u5e8f\uff0c\u53ef\u4ee5\u51c6\u786e\u5730\u6d4b\u91cf\u75c5\u4eba\u7684\u5168\u8eab\u6c34\u5206\u3001\u7ec6\u80de\u5916\u548c\u7ec6\u80de\u5185\u6db2\u4f53\u4f53\u79ef\uff0c\u7528\u4e8e\u65e9\u671f\u68c0\u6d4b\u3001\u8bc4\u4f30\u548c\u5e72\u9884\u6162\u6027\u5065\u5eb7\u72b6\u51b5\u3002<\/p>\n<p>ImpediMed \u7684 SOZO \u6570\u5b57\u5065\u5eb7\u68c0\u67e5\u5e73\u53f0\u662f\u552f\u4e00\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u6279\u51c6\u7684 BIS \u6280\u672f\u3002<\/p>\n<p>\u5b83\u5728\u6709\u6548\u548c\u51c6\u786e\u7b5b\u67e5\u6dcb\u5df4\u6c34\u80bf\u65b9\u9762\u7684\u80fd\u529b\u5df2\u6536\u5230\u5e7f\u6cdb\u7684\u63a5\u53d7\u548c\u8ba4\u53ef\u3002<\/p>\n<h2>\u5168\u7403\u6027\u6807\u51c6<\/h2>\n<p>NCCN \u7684\u300a\u80bf\u7624\u5b66\u5e78\u5b58\u8005\u4e34\u5e8a\u5b9e\u8df5\u6307\u5357\u300b\u662f\u764c\u75c7\u62a4\u7406\u4e34\u5e8a\u65b9\u5411\u548c\u653f\u7b56\u7684\u5168\u7403\u6807\u51c6\uff0c\u76ee\u7684\u662f\u6539\u5584\u75c5\u4eba\u62a4\u7406\u548c\u7ed3\u679c\u3002<\/p>\n<p>\u66f4\u65b0\u540e\u7684\u6307\u5357\u73b0\u5728\u5efa\u8bae\u6709\u6dcb\u5df4\u6c34\u80bf\u98ce\u9669\u7684\u764c\u75c7\u5e78\u5b58\u8005\u5b9a\u671f\u8fdb\u884c\u7b5b\u67e5\uff0c\u901a\u8fc7\u75c7\u72b6\u8bc4\u4f30\u3001\u4e34\u5e8a\u68c0\u67e5\u548c BIS \u53d1\u73b0\u65e9\u671f\u8ff9\u8c61\u3002<\/p>\n<p>BIS \u9996\u6b21\u88ab\u7eb3\u5165\u8be5\u6587\u4ef6\u4e2d\u3002<\/p>\n<p>2020\u5e74\uff0c<a href=\"http:\/\/smallcaps-production.test\/impedimed-nccn-updated-breast-cancer-guidelines-provide-early-lymphoedema-screening\/?lang=cn\">\u66f4\u65b0\u7684 NCCN \u4e73\u817a\u764c\u7b5b\u67e5\u548c\u8bca\u65ad\u76f8\u5173\u6307\u5357<\/a>\u63d0\u5230\u4e86 BIS \u7684\u4f7f\u7528\uff0c\u4f46\u6ca1\u6709\u5177\u4f53\u63d0\u53ca\u5b83\u3002<\/p>\n<h2>\u9a8c\u8bc1\u7684\u65f6\u523b<\/h2>\n<p>ImpediMed \u603b\u7ecf\u7406 Richard Valencia \u8bf4\uff0cBIS \u7684\u52a0\u5165\u5bf9\u8be5\u516c\u53f8\u6765\u8bf4\u662f\u4e00\u4e2a &#8220;\u91cd\u8981\u7684\u9a8c\u8bc1\u65f6\u523b&#8221;\u3002<\/p>\n<p>\u4ed6\u8bf4\uff1a\u201cNCCN \u6307\u5357\u7684\u4f5c\u8005\u662f\u5168\u7403\u764c\u75c7\u6cbb\u7597\u9886\u57df\u7684\u9886\u5bfc\u8005\uff0c\u4ed6\u4eec\u7684\u5efa\u8bae\u5bf9\u4e34\u5e8a\u533b\u751f\u3001\u60a3\u8005\u3001\u653f\u7b56\u5236\u5b9a\u8005\u548c\u4fdd\u9669\u516c\u53f8\u5177\u6709\u5f88\u5927\u7684\u5f71\u54cd\u529b\u3002\u201d<\/p>\n<p>&#8220;\u6211\u4eec\u8fd1\u671f\u7684\u91cd\u70b9\u4ecd\u7136\u662f\u5229\u7528\u6211\u4eec\u5f3a\u5927\u7684\u4e34\u5e8a\u8bc1\u636e\u3001\u5e02\u573a\u5730\u4f4d\u4ee5\u53ca\u73b0\u5728\u7684\u8fd9\u4e9b\u6307\u5357\u6765\u63a8\u52a8\u6211\u4eec\u7684\u4e73\u817a\u764c\u76f8\u5173\u6dcb\u5df4\u6c34\u80bf\u89e3\u51b3\u65b9\u6848\u7684\u589e\u957f\u548c\u91c7\u7528\u3002&#8221;<\/p>\n<p>\u4ed6\u8bf4\uff0c\u8fd9\u4e9b\u6307\u5357\u652f\u6301\u4e86\u4e00\u4e2a\u957f\u671f\u6269\u5c55\u5230\u5176\u4ed6\u764c\u75c7\u7c7b\u578b\u7684\u673a\u4f1a\uff0c\u6709\u53ef\u80fd\u6269\u5927\u516c\u53f8\u5728\u80bf\u7624\u5b66\u9886\u57df\u7684\u8db3\u8ff9\uff0c\u4f7f\u66f4\u591a\u7684\u60a3\u8005\u53d7\u76ca\u3002<\/p>\n<h2>\u4e16\u754c\u4e0a\u6700\u5148\u8fdb\u7684\u8bbe\u5907<\/h2>\n<p>\u636e\u62a5\u9053\uff0cSOZO \u662f\u4e16\u754c\u4e0a\u6700\u5148\u8fdb\u7684\u65e0\u521b BIS \u8bbe\u5907\uff0c\u53ef\u572830\u79d2\u5185\u63d0\u4f9b\u6db2\u4f53\u72b6\u6001\u548c\u7ec4\u7ec7\u6210\u5206\u7684\u7cbe\u786e\u5feb\u7167\u3002<\/p>\n<p>\u5229\u7528 ImpediMed \u7684 BIS \u6280\u672f\uff0cSOZO \u53ef\u4ee5\u5728\u5e7f\u6cdb\u7684\u9891\u7387\u8303\u56f4\u5185\u6d4b\u91cf\u591a\u8fbe256\u4e2a\u72ec\u7279\u7684\u6570\u636e\u70b9\uff0c\u5176\u7ed3\u679c\u53ef\u7acb\u5373\u5728\u7ebf\u63d0\u4f9b\uff0c\u4fbf\u4e8e\u6574\u4e2a\u533b\u7597\u7cfb\u7edf\u7684\u6570\u636e\u8bbf\u95ee\u548c\u5171\u4eab\u3002<\/p>\n<p>SOZO \u6709\u52a9\u4e8e\u65e9\u671f\u53d1\u73b0\u7ee7\u53d1\u6027\u6dcb\u5df4\u6c34\u80bf\uff0c\u4e3a\u60a3\u6709\u5fc3\u810f\u6216\u80be\u8870\u7aed\u7684\u75c5\u4eba\u63d0\u4f9b\u6db2\u4f53\u72b6\u6001\uff0c\u5e76\u53ef\u7528\u4e8e\u76d1\u6d4b\u548c\u7ef4\u6301\u6574\u4f53\u5065\u5eb7\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ImpediMed (ASX: IPD) \u5f00\u53d1\u7684\u7528\u4e8e\u8bc4\u4f30\u6dcb\u5df4\u6c34\u80bf\u7684\u7b5b\u67e5\u5e73\u53f0\uff0c\u968f\u7740\u751f\u7269\u963b\u6297\u5149\u8c31 (BIS) \u5ba3\u5e03\u88ab\u7eb3\u5165\u7f8e\u56fd\u56fd\u5bb6\u7efc\u5408\u764c\u75c7\u7f51\u7edc (NCCN) \u53d1\u5e03\u7684\u80bf\u7624\u5b66\u6307\u5357\uff0c\u6709\u671b\u63d0\u9ad8\u5176\u77e5\u540d\u5ea6\u3002 BIS \u5206\u6790\u662f\u4e00\u79cd\u65e0\u521b\u7684\u3001\u4f4e\u6210\u672c\u7684\u7a0b\u5e8f\uff0c\u53ef\u4ee5\u51c6\u786e\u5730\u6d4b\u91cf\u75c5\u4eba\u7684\u5168\u8eab\u6c34\u5206\u3001\u7ec6\u80de\u5916\u548c\u7ec6\u80de\u5185\u6db2\u4f53\u4f53\u79ef\uff0c\u7528\u4e8e\u65e9\u671f\u68c0\u6d4b\u3001\u8bc4\u4f30\u548c\u5e72\u9884\u6162\u6027\u5065\u5eb7\u72b6\u51b5\u3002 ImpediMed \u7684 SOZO \u6570\u5b57\u5065\u5eb7\u68c0\u67e5\u5e73\u53f0\u662f\u552f\u4e00\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u6279\u51c6\u7684 BIS \u6280\u672f\u3002 \u5b83\u5728\u6709\u6548\u548c\u51c6\u786e\u7b5b\u67e5\u6dcb\u5df4\u6c34\u80bf\u65b9\u9762\u7684\u80fd\u529b\u5df2\u6536\u5230\u5e7f\u6cdb\u7684\u63a5\u53d7\u548c\u8ba4\u53ef\u3002 \u5168\u7403\u6027\u6807\u51c6 NCCN \u7684\u300a\u80bf\u7624\u5b66\u5e78\u5b58\u8005\u4e34\u5e8a\u5b9e\u8df5\u6307\u5357\u300b\u662f\u764c\u75c7\u62a4\u7406\u4e34\u5e8a\u65b9\u5411\u548c\u653f\u7b56\u7684\u5168\u7403\u6807\u51c6\uff0c\u76ee\u7684\u662f\u6539\u5584\u75c5\u4eba\u62a4\u7406\u548c\u7ed3\u679c\u3002 \u66f4\u65b0\u540e\u7684\u6307\u5357\u73b0\u5728\u5efa\u8bae\u6709\u6dcb\u5df4\u6c34\u80bf\u98ce\u9669\u7684\u764c\u75c7\u5e78\u5b58\u8005\u5b9a\u671f\u8fdb\u884c\u7b5b\u67e5\uff0c\u901a\u8fc7\u75c7\u72b6\u8bc4\u4f30\u3001\u4e34\u5e8a\u68c0\u67e5\u548c BIS \u53d1\u73b0\u65e9\u671f\u8ff9\u8c61\u3002 BIS \u9996\u6b21\u88ab\u7eb3\u5165\u8be5\u6587\u4ef6\u4e2d\u3002 2020\u5e74\uff0c\u66f4\u65b0\u7684 NCCN \u4e73\u817a\u764c\u7b5b\u67e5\u548c\u8bca\u65ad\u76f8\u5173\u6307\u5357\u63d0\u5230\u4e86 BIS \u7684\u4f7f\u7528\uff0c\u4f46\u6ca1\u6709\u5177\u4f53\u63d0\u53ca\u5b83\u3002 \u9a8c\u8bc1\u7684\u65f6\u523b ImpediMed \u603b\u7ecf\u7406 Richard Valencia \u8bf4\uff0cBIS \u7684\u52a0\u5165\u5bf9\u8be5\u516c\u53f8\u6765\u8bf4\u662f\u4e00\u4e2a &#8220;\u91cd\u8981\u7684\u9a8c\u8bc1\u65f6\u523b&#8221;\u3002 \u4ed6\u8bf4\uff1a\u201cNCCN \u6307\u5357\u7684\u4f5c\u8005\u662f\u5168\u7403\u764c\u75c7\u6cbb\u7597\u9886\u57df\u7684\u9886\u5bfc\u8005\uff0c\u4ed6\u4eec\u7684\u5efa\u8bae\u5bf9\u4e34\u5e8a\u533b\u751f\u3001\u60a3\u8005\u3001\u653f\u7b56\u5236\u5b9a\u8005\u548c\u4fdd\u9669\u516c\u53f8\u5177\u6709\u5f88\u5927\u7684\u5f71\u54cd\u529b\u3002\u201d &#8220;\u6211\u4eec\u8fd1\u671f\u7684\u91cd\u70b9\u4ecd\u7136\u662f\u5229\u7528\u6211\u4eec\u5f3a\u5927\u7684\u4e34\u5e8a\u8bc1\u636e\u3001\u5e02\u573a\u5730\u4f4d\u4ee5\u53ca\u73b0\u5728\u7684\u8fd9\u4e9b\u6307\u5357\u6765\u63a8\u52a8\u6211\u4eec\u7684\u4e73\u817a\u764c\u76f8\u5173\u6dcb\u5df4\u6c34\u80bf\u89e3\u51b3\u65b9\u6848\u7684\u589e\u957f\u548c\u91c7\u7528\u3002&#8221; \u4ed6\u8bf4\uff0c\u8fd9\u4e9b\u6307\u5357\u652f\u6301\u4e86\u4e00\u4e2a\u957f\u671f\u6269\u5c55\u5230\u5176\u4ed6\u764c\u75c7\u7c7b\u578b\u7684\u673a\u4f1a\uff0c\u6709\u53ef\u80fd\u6269\u5927\u516c\u53f8\u5728\u80bf\u7624\u5b66\u9886\u57df\u7684\u8db3\u8ff9\uff0c\u4f7f\u66f4\u591a\u7684\u60a3\u8005\u53d7\u76ca\u3002 \u4e16\u754c\u4e0a\u6700\u5148\u8fdb\u7684\u8bbe\u5907 \u636e\u62a5\u9053\uff0cSOZO \u662f\u4e16\u754c\u4e0a\u6700\u5148\u8fdb\u7684\u65e0\u521b BIS \u8bbe\u5907\uff0c\u53ef\u572830\u79d2\u5185\u63d0\u4f9b\u6db2\u4f53\u72b6\u6001\u548c\u7ec4\u7ec7\u6210\u5206\u7684\u7cbe\u786e\u5feb\u7167\u3002 \u5229\u7528 ImpediMed \u7684 BIS \u6280\u672f\uff0cSOZO \u53ef\u4ee5\u5728\u5e7f\u6cdb\u7684\u9891\u7387\u8303\u56f4\u5185\u6d4b\u91cf\u591a\u8fbe256\u4e2a\u72ec\u7279\u7684\u6570\u636e\u70b9\uff0c\u5176\u7ed3\u679c\u53ef\u7acb\u5373\u5728\u7ebf\u63d0\u4f9b\uff0c\u4fbf\u4e8e\u6574\u4e2a\u533b\u7597\u7cfb\u7edf\u7684\u6570\u636e\u8bbf\u95ee\u548c\u5171\u4eab\u3002 SOZO \u6709\u52a9\u4e8e\u65e9\u671f\u53d1\u73b0\u7ee7\u53d1\u6027\u6dcb\u5df4\u6c34\u80bf\uff0c\u4e3a\u60a3\u6709\u5fc3\u810f\u6216\u80be\u8870\u7aed\u7684\u75c5\u4eba\u63d0\u4f9b\u6db2\u4f53\u72b6\u6001\uff0c\u5e76\u53ef\u7528\u4e8e\u76d1\u6d4b\u548c\u7ef4\u6301\u6574\u4f53\u5065\u5eb7\u3002<\/p>\n","protected":false},"author":4,"featured_media":19025,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[618],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ImpediMed \u7684 BIS \u6280\u672f\u53d7\u5230\u8ba4\u53ef\u4e14\u88ab NCCN \u7eb3\u5165\u80bf\u7624\u5b66\u6307\u5357\uff0c\u7528\u4e8e\u6dcb\u5df4\u6c34\u80bf\u8bc4\u4f30\u3002<\/title>\n<meta name=\"description\" content=\"ImpediMed (ASX: IPD) \u5f00\u53d1\u7684\u7528\u4e8e\u8bc4\u4f30\u6dcb\u5df4\u6c34\u80bf\u7684\u7b5b\u67e5\u5e73\u53f0\uff0c\u968f\u7740\u751f\u7269\u963b\u6297\u5149\u8c31 (BIS) \u5ba3\u5e03\u88ab\u7eb3\u5165\u7f8e\u56fd\u56fd\u5bb6\u7efc\u5408\u764c\u75c7\u7f51\u7edc (NCCN) \u53d1\u5e03\u7684\u80bf\u7624\u5b66\u6307\u5357\uff0c\u6709\u671b\u63d0\u9ad8\u5176\u77e5\u540d\u5ea6\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ImpediMed \u7684 BIS \u6280\u672f\u53d7\u5230\u8ba4\u53ef\u4e14\u88ab NCCN \u7eb3\u5165\u80bf\u7624\u5b66\u6307\u5357\uff0c\u7528\u4e8e\u6dcb\u5df4\u6c34\u80bf\u8bc4\u4f30\" \/>\n<meta property=\"og:description\" content=\"ImpediMed (ASX: IPD) \u5f00\u53d1\u7684\u7528\u4e8e\u8bc4\u4f30\u6dcb\u5df4\u6c34\u80bf\u7684\u7b5b\u67e5\u5e73\u53f0\uff0c\u968f\u7740\u751f\u7269\u963b\u6297\u5149\u8c31 (BIS) \u5ba3\u5e03\u88ab\u7eb3\u5165\u7f8e\u56fd\u56fd\u5bb6\u7efc\u5408\u764c\u75c7\u7f51\u7edc (NCCN) \u53d1\u5e03\u7684\u80bf\u7624\u5b66\u6307\u5357\uff0c\u6709\u671b\u63d0\u9ad8\u5176\u77e5\u540d\u5ea6\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/impedimed-bis-technology-nccn-includes-oncology-guidelines-lymphoedema-assessment\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-27T01:37:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:57:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/ImpediMed-ASX-IPD-Lymphoedema-Bioimpedance-Spectroscopy-NCCN-National-Comprehensive-Cancer-Network.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/impedimed-bis-technology-nccn-includes-oncology-guidelines-lymphoedema-assessment\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/impedimed-bis-technology-nccn-includes-oncology-guidelines-lymphoedema-assessment\/\",\"name\":\"ImpediMed \u7684 BIS \u6280\u672f\u53d7\u5230\u8ba4\u53ef\u4e14\u88ab NCCN \u7eb3\u5165\u80bf\u7624\u5b66\u6307\u5357\uff0c\u7528\u4e8e\u6dcb\u5df4\u6c34\u80bf\u8bc4\u4f30\u3002\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2023-03-27T01:37:22+00:00\",\"dateModified\":\"2023-08-29T17:57:23+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"ImpediMed (ASX: IPD) \u5f00\u53d1\u7684\u7528\u4e8e\u8bc4\u4f30\u6dcb\u5df4\u6c34\u80bf\u7684\u7b5b\u67e5\u5e73\u53f0\uff0c\u968f\u7740\u751f\u7269\u963b\u6297\u5149\u8c31 (BIS) \u5ba3\u5e03\u88ab\u7eb3\u5165\u7f8e\u56fd\u56fd\u5bb6\u7efc\u5408\u764c\u75c7\u7f51\u7edc (NCCN) \u53d1\u5e03\u7684\u80bf\u7624\u5b66\u6307\u5357\uff0c\u6709\u671b\u63d0\u9ad8\u5176\u77e5\u540d\u5ea6\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/impedimed-bis-technology-nccn-includes-oncology-guidelines-lymphoedema-assessment\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/impedimed-bis-technology-nccn-includes-oncology-guidelines-lymphoedema-assessment\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/impedimed-bis-technology-nccn-includes-oncology-guidelines-lymphoedema-assessment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ImpediMed \u7684 BIS \u6280\u672f\u53d7\u5230\u8ba4\u53ef\u4e14\u88ab NCCN \u7eb3\u5165\u80bf\u7624\u5b66\u6307\u5357\uff0c\u7528\u4e8e\u6dcb\u5df4\u6c34\u80bf\u8bc4\u4f30\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ImpediMed \u7684 BIS \u6280\u672f\u53d7\u5230\u8ba4\u53ef\u4e14\u88ab NCCN \u7eb3\u5165\u80bf\u7624\u5b66\u6307\u5357\uff0c\u7528\u4e8e\u6dcb\u5df4\u6c34\u80bf\u8bc4\u4f30\u3002","description":"ImpediMed (ASX: IPD) \u5f00\u53d1\u7684\u7528\u4e8e\u8bc4\u4f30\u6dcb\u5df4\u6c34\u80bf\u7684\u7b5b\u67e5\u5e73\u53f0\uff0c\u968f\u7740\u751f\u7269\u963b\u6297\u5149\u8c31 (BIS) \u5ba3\u5e03\u88ab\u7eb3\u5165\u7f8e\u56fd\u56fd\u5bb6\u7efc\u5408\u764c\u75c7\u7f51\u7edc (NCCN) \u53d1\u5e03\u7684\u80bf\u7624\u5b66\u6307\u5357\uff0c\u6709\u671b\u63d0\u9ad8\u5176\u77e5\u540d\u5ea6\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"ImpediMed \u7684 BIS \u6280\u672f\u53d7\u5230\u8ba4\u53ef\u4e14\u88ab NCCN \u7eb3\u5165\u80bf\u7624\u5b66\u6307\u5357\uff0c\u7528\u4e8e\u6dcb\u5df4\u6c34\u80bf\u8bc4\u4f30","og_description":"ImpediMed (ASX: IPD) \u5f00\u53d1\u7684\u7528\u4e8e\u8bc4\u4f30\u6dcb\u5df4\u6c34\u80bf\u7684\u7b5b\u67e5\u5e73\u53f0\uff0c\u968f\u7740\u751f\u7269\u963b\u6297\u5149\u8c31 (BIS) \u5ba3\u5e03\u88ab\u7eb3\u5165\u7f8e\u56fd\u56fd\u5bb6\u7efc\u5408\u764c\u75c7\u7f51\u7edc (NCCN) \u53d1\u5e03\u7684\u80bf\u7624\u5b66\u6307\u5357\uff0c\u6709\u671b\u63d0\u9ad8\u5176\u77e5\u540d\u5ea6\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/impedimed-bis-technology-nccn-includes-oncology-guidelines-lymphoedema-assessment\/","og_site_name":"smallcapsCN","article_published_time":"2023-03-27T01:37:22+00:00","article_modified_time":"2023-08-29T17:57:23+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/ImpediMed-ASX-IPD-Lymphoedema-Bioimpedance-Spectroscopy-NCCN-National-Comprehensive-Cancer-Network.jpg","type":"image\/jpeg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/impedimed-bis-technology-nccn-includes-oncology-guidelines-lymphoedema-assessment\/","url":"https:\/\/smallcapscn.x5view.co\/impedimed-bis-technology-nccn-includes-oncology-guidelines-lymphoedema-assessment\/","name":"ImpediMed \u7684 BIS \u6280\u672f\u53d7\u5230\u8ba4\u53ef\u4e14\u88ab NCCN \u7eb3\u5165\u80bf\u7624\u5b66\u6307\u5357\uff0c\u7528\u4e8e\u6dcb\u5df4\u6c34\u80bf\u8bc4\u4f30\u3002","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2023-03-27T01:37:22+00:00","dateModified":"2023-08-29T17:57:23+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"ImpediMed (ASX: IPD) \u5f00\u53d1\u7684\u7528\u4e8e\u8bc4\u4f30\u6dcb\u5df4\u6c34\u80bf\u7684\u7b5b\u67e5\u5e73\u53f0\uff0c\u968f\u7740\u751f\u7269\u963b\u6297\u5149\u8c31 (BIS) \u5ba3\u5e03\u88ab\u7eb3\u5165\u7f8e\u56fd\u56fd\u5bb6\u7efc\u5408\u764c\u75c7\u7f51\u7edc (NCCN) \u53d1\u5e03\u7684\u80bf\u7624\u5b66\u6307\u5357\uff0c\u6709\u671b\u63d0\u9ad8\u5176\u77e5\u540d\u5ea6\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/impedimed-bis-technology-nccn-includes-oncology-guidelines-lymphoedema-assessment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/impedimed-bis-technology-nccn-includes-oncology-guidelines-lymphoedema-assessment\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/impedimed-bis-technology-nccn-includes-oncology-guidelines-lymphoedema-assessment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"ImpediMed \u7684 BIS \u6280\u672f\u53d7\u5230\u8ba4\u53ef\u4e14\u88ab NCCN \u7eb3\u5165\u80bf\u7624\u5b66\u6307\u5357\uff0c\u7528\u4e8e\u6dcb\u5df4\u6c34\u80bf\u8bc4\u4f30"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6594"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6594"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6594\/revisions"}],"predecessor-version":[{"id":20392,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6594\/revisions\/20392"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/19025"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6594"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6594"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}